Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,773 | 24 | -12,859 | -14,913 | -9,187 |
| Depreciation Amortization | 124 | 170 | 262 | 251 | 223 |
| Accounts receivable | 735 | 1,320 | -311 | 69 | -226 |
| Accounts payable and accrued liabilities | -572 | 572 | -8 | -268 | 479 |
| Other Working Capital | -3,208 | 2,222 | -57 | -368 | -354 |
| Other Operating Activity | 3,073 | -1,446 | 320 | 148 | -4,035 |
| Operating Cash Flow | $-3,621 | $2,862 | $-12,652 | $-15,080 | $-13,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -144 | -163 | -101 | -595 |
| Investing Cash Flow | $-48 | $-144 | $-163 | $-101 | $-595 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | 19 | N/A | 6,667 | 20,142 |
| Other Financing Activity | 0 | 0 | 12,910 | 0 | -3,206 |
| Financing Cash Flow | $15 | $19 | $12,910 | $6,667 | $16,935 |
| Beginning Cash Position | 6,780 | 4,044 | 3,949 | 12,463 | 9,222 |
| End Cash Position | 3,126 | 6,780 | 4,044 | 3,949 | 12,463 |
| Net Cash Flow | $-3,654 | $2,737 | $95 | $-8,514 | $3,241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,621 | 2,862 | -12,652 | -15,080 | -13,100 |
| Capital Expenditure | -48 | -144 | -163 | -101 | -595 |
| Free Cash Flow | -3,669 | 2,718 | -12,816 | -15,181 | -13,695 |